Zobrazeno 1 - 10 of 301 pro vyhledávání: '"Kk, Matthay"'
3
Comparison of anti-Tac and anti-transferrin receptor-conjugated liposomes for specific drug delivery to adult T-cell leukemia
Autor: KM Hege, DL Daleke, TA Waldmann, KK Matthay
Publikováno v: Blood. 74(6)
Adult T-cell leukemia (ATL) is a rapidly progressive and usually fatal malignancy of mature T cells characterized by the expression of large numbers of interleukin-2 (IL-2) receptors on the cell surface. Anti- Tac, a monoclonal antibody directed agai
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41ee3ce10baee75c36a0033db5d802da
https://pubmed.ncbi.nlm.nih.gov/2679914
Zobrazit plný text záznamu
6
Akademický článek
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
Autor: Barr EK; Department of Pediatrics, Texas Tech University Health Sciences, Lubbock, Texas, USA., Naranjo A; Department of Biostatistics, University of Florida Children's Oncology Group Statistics and Data Center, Gainesville, Florida, USA., Twist CJ; Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Tenney SC; Department of Biostatistics, University of Florida Children's Oncology Group Statistics and Data Center, Gainesville, Florida, USA., Schmidt ML; Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois, USA., London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Gastier-Foster J; Department of Pediatrics and Pathology/Immunology, Baylor College of Medicine, Houston, Texas, USA., Adkins ES; Department of Pediatrics, Palmetto Health-USC Medical Group, Columbia, South Carolina, USA., Mattei P; Department of Surgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Handler MH; Department of Neurosurgery, Children's Hospital Colorado, Aurora, Colorado, USA., Matthay KK; Department of Pediatrics, University of California San Francisco School of Medicine, San Francisco, California, USA., Park JR; Department of Oncology, St.Jude Children's Research Hospital, Memphis, Tennessee, USA., Maris JM; Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Desai AV; Department of Pediatrics, University of Chicago, Chicago, Illinois, USA., Cohn SL; Department of Pediatrics, University of Chicago, Chicago, Illinois, USA.
Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Aug; Vol. 71 (8), pp. e31089. Date of Electronic Publication: 2024 May 31.
Zobrazit plný text záznamu
7
Akademický článek
Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
Autor: Kumar P; Pediatrics, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA., Willard VW; Psychology & Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Embry L; Pediatrics, UT Health San Antonio, San Antonio, Texas, USA., Naranjo A; Biostatistics, Children's Oncology Group Statistics & Data Center, University of Florida, Gainesville, Florida, USA., LaBarre B; Biostatistics, Children's Oncology Group Statistics & Data Center, University of Florida, Gainesville, Florida, USA., Matthay KK; Pediatric Oncology, University of California San Francisco School of Medicine and UCSF Benioff Children's Hospital, San Francisco, California, USA., de Alarcon PA; Pediatrics, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA.
Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Jul; Vol. 71 (7), pp. e31039. Date of Electronic Publication: 2024 Apr 30.
Zobrazit plný text záznamu
8
Akademický článek
Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131 I-MIBG therapy in high-risk neuroblastoma.
Autor: Kumar P; Department of Pediatrics, University of Illinois College of Medicine at Peoria, 530 NE Glen Oak Ave, Peoria, IL, 61637, USA. prerna@uic.edu.; Department of Pediatrics, University of California, San Francisco, CA, USA. prerna@uic.edu., Koach J; Department of Pediatrics, University of California, San Francisco, CA, USA., Nekritz E; Department of Pediatrics, University of California, San Francisco, CA, USA., Mukherjee S; Department of Pediatrics, University of California, San Francisco, CA, USA., Braun BS; Department of Pediatrics, University of California, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Nasholm N; Department of Pediatrics, University of California, San Francisco, CA, USA., Haas-Kogan D; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Matthay KK; Department of Pediatrics, University of California, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA., Weiss WA; Department of Pediatrics, University of California, San Francisco, CA, USA.; Departments of Neurology, Neurosurgery, and Brain Tumor Research Center, University of California San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA., Gustafson C; Department of Pediatrics, University of California, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA., Seo Y; Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA.
Publikováno v: EJNMMI research [EJNMMI Res] 2024 Jun 13; Vol. 14 (1), pp. 54. Date of Electronic Publication: 2024 Jun 13.
Zobrazit plný text záznamu
9
Akademický článek
ALK upregulates POSTN and WNT signaling to drive neuroblastoma.
Autor: Huang M; Children's Hospital Los Angeles, Cancer and Blood Disease Institutes, and The Saban Research Institute, Los Angeles, CA, USA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Electronic address: mhuang@chla.usc.edu., Fang W; Children's Hospital Los Angeles, Cancer and Blood Disease Institutes, and The Saban Research Institute, Los Angeles, CA, USA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Farrel A; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Li L; Children's Hospital Los Angeles, Cancer and Blood Disease Institutes, and The Saban Research Institute, Los Angeles, CA, USA., Chronopoulos A; Children's Hospital Los Angeles, Cancer and Blood Disease Institutes, and The Saban Research Institute, Los Angeles, CA, USA., Nasholm N; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Cheng B; Children's Hospital Los Angeles, Cancer and Blood Disease Institutes, and The Saban Research Institute, Los Angeles, CA, USA., Zheng T; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Yoda H; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Barata MJ; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Porras T; Children's Hospital Los Angeles, Cancer and Blood Disease Institutes, and The Saban Research Institute, Los Angeles, CA, USA., Miller ML; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Zhen Q; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Ghiglieri L; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., McHenry L; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Wang L; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Asgharzadeh S; Children's Hospital Los Angeles, Cancer and Blood Disease Institutes, and The Saban Research Institute, Los Angeles, CA, USA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Park J; Children's Hospital Los Angeles, Cancer and Blood Disease Institutes, and The Saban Research Institute, Los Angeles, CA, USA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Gustafson WC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA; Departments of Pediatrics and Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Matthay KK; Departments of Pediatrics and Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Maris JM; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Weiss WA; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA; Departments of Pediatrics and Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA. Electronic address: waweiss@gmail.com.
Publikováno v: Cell reports [Cell Rep] 2024 Mar 26; Vol. 43 (3), pp. 113927. Date of Electronic Publication: 2024 Mar 06.
Zobrazit plný text záznamu
10
Akademický článek
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.
Autor: Hogarty MD; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. hogartym@chop.edu.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. hogartym@chop.edu., Ziegler DS; Children's Cancer Institute, Lowy Cancer Research Centre, Randwick, NSW, Australia.; School of Women's and Children's Health, University of New South Wales, Sydney, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia., Franson A; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA., Chi YY; Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA., Tsao-Wei D; Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA., Liu K; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Vemu R; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Gerner EW; Cancer Prevention Pharmaceuticals, Tucson, AZ, USA., Bruckheimer E; Panbela Pharmaceuticals, Inc., Waconia, MN, USA., Shamirian A; Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA., Hasenauer B; Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA., Balis FM; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Groshen S; Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA., Norris MD; Children's Cancer Institute, Lowy Cancer Research Centre, Randwick, NSW, Australia., Haber M; Children's Cancer Institute, Lowy Cancer Research Centre, Randwick, NSW, Australia., Park JR; St. Jude Children's Research Hospital, University of Tennessee, Memphis, TN, USA., Matthay KK; UCSF Benioff Children's Hospital, UCSF School of Medicine, University of California San Francisco, San Francisco, CA, USA., Marachelian A; Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Publikováno v: British journal of cancer [Br J Cancer] 2024 Mar; Vol. 130 (5), pp. 788-797. Date of Electronic Publication: 2024 Jan 10.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje